Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancer Nobuyuki YamamotoYasumasa NishimuraMasahiro Fukuoka Original Article 17 January 2006 Pages: 285 - 291
Pharmacokinetics and pharmacodynamics of irinotecan and its metabolites from plasma and saliva data in patients with metastatic digestive cancer receiving Folfiri regimen Sylvain PoujolFrançoise BressolleFrédéric Pinguet Original Article 21 December 2005 Pages: 292 - 305
Liposome formulation of a novel hydrophobic aryl-imidazole compound for anti-cancer therapy Jubo LiuHelen LeeChristine Allen Original Article 07 December 2005 Pages: 306 - 318
Clindamycin–paclitaxel pharmacokinetic interaction in ovarian cancer patients Robert FruscioAndrea A. LissoniMassimo Zucchetti Original Article 13 December 2005 Pages: 319 - 325
Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents Y.-L. LiuN. M. MalikP. L. R. Andrews Original Article 25 January 2006 Pages: 326 - 333
Repopulation of osteosarcoma cells after treatment with doxorubicin in the presence of extracellular matrix biopolymers Revekka HarisiJózsef DudásAndrás Jeney Original Article 14 March 2006 Pages: 334 - 342
Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children’s Oncology Group K. WarrenR. JakackiF. M. Balis Original Article 12 January 2006 Pages: 343 - 347
Indomethacin overcomes doxorubicin resistance with inhibiting multi-drug resistance protein 1 (MRP1) Seita MatsunagaTakeshi AsanoYoshitaka Fukunaga Original Article 06 December 2005 Pages: 348 - 353
The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondin Jan-Erik DamberChristina VallboKlas Norrby Original Article 07 December 2005 Pages: 354 - 360
The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer Takashi HiroseYoshihide MizutaniMitsuru Adachi Original Article 06 December 2005 Pages: 361 - 367
A multicenter phase II study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer: Kyushu thoracic oncology group trial Masao IchikiMasayuki KawasakiYoichi Nakanishi Original Article 04 January 2006 Pages: 368 - 373
Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan Anshul GuptaYang DaiQingcheng Mao Original Article 11 January 2006 Pages: 374 - 383
Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells Timothy C. ChengGerald ManorekStephen B. Howell Original Article 11 January 2006 Pages: 384 - 395
Dihydropyrimidine dehydrogenase deficiency in an Indian population Muhammad Wasif SaifLori MattisonRobert B. Diasio Original Article 19 January 2006 Pages: 396 - 401
Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy Nobuo ShinoharaToru HarabayashiKatsuya Nonomura Original Article 17 January 2006 Pages: 402 - 407
The cytotoxic and genotoxic potential of 5-aminolevulinic acid on lymphocytes: a comet assay study E. S. M. ChuR. W. K. WuJ. Y. Chen Original Article 12 January 2006 Pages: 408 - 414
Biliary excretion of etoposide in children with cancer Gareth J. VealJulie ErringtonStephen Lowis Short Communication 18 January 2006 Pages: 415 - 417
Pharmacodynamic properties of methotrexate and AminotrexateTM during weekly therapy Peter D. ColeJohn A. ZebalaBarton A. Kamen Erratum 10 May 2006 Pages: 418 - 418
